USC hair dye study

January 23, 2001

USC study finds use of permanent hair dyes tied to increased risk of bladder cancer

LOS ANGELES, Jan. 2001--Women who regularly color their hair with permanent hair dyes--as well as hair stylists who work with such chemicals--are at greater risk for bladder cancer, according to a study from researchers at the Keck School of Medicine of the University of Southern California.

Even after adjusting for cigarette smoking (a known risk factor in bladder cancer), women who use permanent dyes at least once a month for one year or longer have twice the risk of bladder cancer as non-users, according to the study in a February issue of the International Journal of Cancer. Monthly or more frequent users of 15 or more years experience three times that risk.

The increase in bladder cancer risk was also observed in those who were exposed to hair dyes in their work; i.e., barbers and hairdressers.

The research team, part of the USC/Norris Comprehensive Cancer Center, conducted the epidemiological study with 1,514 bladder cancer patients in Los Angeles, comparing them to another 1,514 similar people who lived in the same neighborhoods. They interviewed participants about health, lifestyle habits and occupations.

"Our bladder cancer study is the first to examine personal hair-dye use by the three major categories of dyes - permanent, semi-permanent, and temporary dyes," says Manuela Gago-Dominguez, M.D., Ph.D., USC researcher in Preventive Medicine and lead author of the study.

Researchers said the association with increased cancer risk was found only with permanent dyes, not semi-permanent or temporary hair color, which rinses out and fades after a series of shampoos.

"Our study is the first to demonstrate a frequency- and duration-dependent association between personal use of permanent hair-dyes and bladder cancer risk. Our novel observations are provocative and carry enormous public health implications. One should bear in mind, however, that these findings require confirmation before such exposure can be regarded as causal factors in bladder cancer development," explains Mimi C. Yu, Ph.D., USC Professor of Preventive Medicine and one of the study authors.

Bladder cancer currently accounts for 6 percent of all new cancer cases in men and 2 percent of all new cancer cases in women. The American Cancer Society estimates that 53,200 Americans were diagnosed with the cancer and 12,200 Americans died from it in 2000.

Besides cigarette smoking, researchers say that exposure to arylamines--a family of chemicals--is a known risk factor for the disease.

Arylamines in hair dye have been found to cause cancer in experimental animals, according to previous studies, and small amounts of these substances are absorbed through the skin during normal use. The body later expels the chemicals through urine, passing through the bladder.

Around the world, millions of people use hair dyes. More than one in three women over age 18 and one in ten men over age 40 throughout Europe, North America and Japan use some type of hair coloring, the researchers report, and permanent dyes account for about three-quarters of the global use.

In the USC study, researchers not only looked at those who used dye on their own tresses, but also those who used it as part of their job. The team found that those in the study who had worked as hairdressers or barbers for 10 years or longer faced a risk of bladder cancer five times greater than the general population. Overall, those who had ever worked as a hairdresser or barber for at least one year experienced a 50 percent greater risk of such cancer.

About 2 million people work as hairdressers and barbers in North America and Europe alone, the researchers say.
The study was funded through a grant by the National Cancer Institute.

University of Southern California

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to